IBI Ag
IBI Ag is an Israeli agritech startup developing selective bioinsecticides based on single-domain antibody technologies for lower-impact crop protection.
Visit WebsiteCompany Overview
IBI Ag focuses on biological crop protection alternatives that reduce environmental impact while preserving agricultural productivity. Its platform leverages antibody-based mechanisms to target pest species with higher selectivity.
The company operates in sustainable agriculture and crop protection, where demand is rising for safer, lower-footprint solutions. Differentiation depends on efficacy, scalability, regulatory progress, and farmer adoption economics.
Dual-use relevance is plausible in food-system resilience: advanced crop protection technologies can support national supply stability and preparedness in disruption-prone environments.
Dual-Use Assessment
Selective biological pest-control platforms are dual-use resilience technologies supporting commercial agriculture and strategic food-system stability.
Key Technologies
- Single-domain antibody bioinsecticide platform
- Selective pest-targeting biological control methods
- Bioprocess development for scalable production
- Crop-protection efficacy optimization workflows
- Regulatory development pathways for sustainable ag inputs
Use Cases & Applications
- Reducing chemical pesticide dependency in agriculture
- Improving crop protection selectivity and sustainability
- Supporting yield stability under environmental constraints
- Advancing biological pest-control adoption in commercial farming
- Contributing to strategic food resilience planning through safer crop protection
Strategic Value to U.S.-Israel Alliance
Supports allied food-system resilience through innovative, lower-footprint crop protection capabilities.
Interested in this startup?
Learn more about our investment approach or get in touch to discuss opportunities in dual-use technology.